TC
UTHR icon

Torno Capital’s United Therapeutics UTHR Stock Holding History

Torno Capital’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-27,000
Closed -$9.68M – 255
2024
Q3 		$9.68M Buy
+27,000
New +$9.12M 1.47% 17

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Torno Capital's UTHR Position: Q4 2024 in Review

Torno Capital sold out of United Therapeutics (UTHR) in Q4 2024, closing a stake of 4,000 shares — an estimated $1.43M sold.

Torno Capital first reported a position in UTHR in Q3 2024 and held it in 1 quarter. The position peaked at $1.43M in Q3 2024. 673 funds tracked by Wall St. Rank hold UTHR as of Q4 2024.

  • Torno Capital reported no remaining United Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Torno Capital sold 4,000 United Therapeutics shares in Q4 2024, an estimated $1.43M.
  • Torno Capital first reported a position in United Therapeutics in Q3 2024 and held it in 1 quarter.
  • Torno Capital's United Therapeutics position peaked at $1.43M in Q3 2024.
  • 673 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2024.

Based on Torno Capital's 13F filing for Q4 2024, filed 14 Feb 2025.